PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1699443
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1699443
Europe and MEA Culture Test for Healthcare-associated Infections Market, By Product Type, By Test Type, By Application, By Sample Type, By End User
Europe and MEA Culture Test for Healthcare-associated Infections Market is estimated to be valued at US$ 299.1 Mn in 2025 and is expected to reach US$ 370.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 3.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 299.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 3.10% | 2032 Value Projection: | USD 370.3 Mn |
It has been gaining steady traction in Europe and the Middle East & Africa region (MEA) over the past few years. Health-associated infections or nosocomial infections that have picked up in healthcare settings, such as hospitals, outpatient clinics, and long-term care facilities, have emerged as a major public health concern. A key aspect in tackling such infections is to understand the microbial flora and identify pathogen presence through appropriate testing measures. Culture tests are being increasingly relied upon by healthcare facilities to provide valuable information about antibiotic resistance and susceptibility patterns of identified bacterial and fungal strains. This aids clinicians in optimizing antibiotic therapy and curbing inappropriate usage. As healthcare systems focus on improving patient safety and clinical outcomes, the demand for advanced culture diagnostic solutions from Europe and MEA is likely to rise significantly in the coming years.
Market Dynamics:
Surging geriatric population and rising incidence of chronic diseases driving longer hospital stays have contributed to the increased risk of patients acquiring infections while undergoing medical care. This has catapulted healthcare-associated infections to the forefront as a serious issue requiring multidisciplinary mitigation strategies. There is growing awareness among the medical fraternity about the role of rapid and accurate laboratory diagnostics for improving antibiotic stewardship and guiding the administration of targeted treatments. Furthermore, supportive regulatory environment promoting the adoption of optimal infection prevention and control measures bodes well for market players. However, budgetary constraints of healthcare facilities, especially in the price sensitive MEA region, remains a key challenge. Ongoing R&D investment by industry players to develop advanced testing techniques with reduced turnaround time and automation could unlock new opportunities for portfolio expansion.
Key Features of the Study:
This report provides in-depth analysis of the Europe and MEA culture test for healthcare-associated infections market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key companies covered as a part of this study include Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Steris Plc, Hologic, Inc., bioMerieux SA, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Hardy Diagnostics, Bio-Rad Laboratories, Inc., Danaher Corporation, SSI Diagnostica A/S, Cepheid, and QIAGEN N.V.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Europe and MEA culture test for healthcare-associated infections market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe and MEA culture test for healthcare-associated infections market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Instruments
- Automated Culture Systems
- Incubators
- Analyzers
- Reagents and Consumables
- Culture Media
- Test Kits
- Antimicrobial Susceptibility Testing Kits
- Test Type Insights (Revenue, USD Mn, 2020 - 2032)
- Bacterial Culture Tests
- Aerobic Bacteria
- Anaerobic Bacteria
- Fungal Culture Tests
- Viral Culture Tests
- Mixed Infection Tests
- Application Insights (Revenue, USD Mn, 2020 - 2032)
- Surgical Site Infections
- Bloodstream Infections
- Urinary Tract Infections
- Respiratory Infections
- Gastrointestinal Infections
- Sample Type Insights (Revenue, USD Mn, 2020 - 2032)
- Blood
- Urine
- Stool
- Tissue
- Others
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals & Clinics
- Nursing Homes
- Diagnostic Laboratories
- Research Institutions
- Ambulatory Surgical Centers
- Others
- Key Players Insights
- Abbott Laboratories
- Merck KGaA
- Becton Dickinson and Company
- Steris Plc
- Hologic, Inc.
- bioMerieux SA
- F. Hoffmann-La Roche AG
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Hardy Diagnostics
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- SSI Diagnostica A/S
- Cepheid
- QIAGEN N.V.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Europe and MEA Culture Test for Healthcare-associated Infections Market, By Product Type
- Europe and MEA Culture Test for Healthcare-associated Infections Market, By Test Type
- Europe and MEA Culture Test for Healthcare-associated Infections Market, By Application
- Europe and MEA Culture Test for Healthcare-associated Infections Market, By Sample Type
- Europe and MEA Culture Test for Healthcare-associated Infections Market, By End User
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Europe and MEA Culture Test for Healthcare-associated Infections Market, By Product Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Automated Culture Systems
- Incubators
- Analyzers
- Reagents and Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Culture Media
- Test Kits
- Antimicrobial Susceptibility Testing Kits
5. Europe and MEA Culture Test for Healthcare-associated Infections Market, By Test Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Bacterial Culture Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Aerobic Bacteria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Anaerobic Bacteria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Fungal Culture Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Viral Culture Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Mixed Infection Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Europe and MEA Culture Test for Healthcare-associated Infections Market, By Application, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Surgical Site Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Bloodstream Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Gastrointestinal Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Europe and MEA Culture Test for Healthcare-associated Infections Market, By Sample Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Stool
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Tissue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Europe and MEA Culture Test for Healthcare-associated Infections Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Nursing Homes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Steris Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F.Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Hardy Diagnostics
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- SSI Diagnostica A/S
- Cepheid
- QIAGEN N.V.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
